32 [IQR 12–37] months, p = 0.17), although this difference did not reach statistical significance ( p = 0.17), regardless of access to further treatment lines.
← all excerpts
Modified Charlson Comorbidity Index to Improve Management of Patients with Hepatocellular Carcinoma: A Step Towards Multiparametric Approach.
1
0.1700
0.1700